---
title: "Cancer signaling, tumor microenvironment, and immunotherapy"
date: "2022-08-08"
---



# Required

Dr. Kun Ping Lu's readings:

- [Zhou XZ and Lu KP (2016) The isomerase PIN1 controls numerous cancer-driving pathways  and is a unique drug target](https://www.nature.com/articles/nrc.2016.49)


- [Koikawa et al. (2016) Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy](https://www.cell.com/cell/fulltext/S0092-8674(21)00879-5?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867421008795%3Fshowall%3Dtrue)

# Complementary reading


# Action items  



# Points of reflection

